Condition
Cerebral Embolism
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02621749Not ApplicableTerminatedPrimary
Cerebral Microembolism in the Critically Ill With Acute Kidney Injury
NCT03802760CompletedPrimary
Cerebral Microembolism in Cardiology
NCT02378116Not ApplicableCompleted
Left Atrial Appendage Closure During Open Heart Surgery
NCT02021045Completed
Cerebral Microembolism During Hemodialysis
NCT01028794Phase 1CompletedPrimary
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
Showing all 5 trials